Pirmitegravir

N/A

Report date: 2024/04/30 14:30:03
NME

Base Information

Drug NamePirmitegravir
Drug Alias NameSTP-0404STP-03-0404STP0404
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV integrase inhibitors
TargetsHIV integrase
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSt Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSt Pharm Co LtdColorado State University FoundationEmory University
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A